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The objective of this study was to design and evaluate transdermal patches of 
Indomethacine using HPMC, EC and Eudragit RLPO using solvent casting technique.  
The in vitro drug release studies were performed by using the USP (paddle type) 
dissolution list apparatus in 1000 ml of 0.1N HCl (Medium Employed) at 37o C room 
temperature for an rpm maintained at 100 within a stipulated time interval of 15 minutes. 
The withdrawn Samples were analyzed by using UV visible spectrophotometer at 268 
mm using regent blank.  The prepared transdermal patches had undergone physic 
chemical evaluator parameters such as PMA, PML, swelling index, water vapour 
transmission rate, film thickness, weight cheek, and folding Endurance and drug content 
clearance.  In vitro dissolution study of drug along with different combination of 
polymers; i.e. HPMC, EC and Eudragit has been performed; out of which batch B6 shows 
the best moisture of films and the graph representing the best controlled drug release.  
As the percentage of ethyl cellulose was reduced the rate of the release of the drug was 
increased.  [Batch B6 > HPMC: EC: Eudragit RLPO - 2:1:2].  Films with batch code B6 
shows better stability and suitability.  Higuchi’s plot revealed that the predominant 
Mechanism of drug release was diffusion  
 
Key Words: Indomethacine, Eudragit RLPO, Controlled release, Fabrication solvent casting 
technique. 
 
 
Sustained release, sustained action, 
prolonged action, controlled release 
extended action, timed release, depot and 
repository dosage forms are certain terms 
used to identify drug delivery system that 
are designed to achieve a prolonged 
therapeutic effect by continuously releasing 
Medication over our extended period of 
time after administration of a single dose.  
The term controlled release has become 
associated with that system from which 
therapeutic agents may automatically 
delivered at pre-defined rates over as long 
period of time products of this type have 
been formulated for oral, injectable and 
topical use, and include insets for 
placement in body cavities as well. 
The terms transdermal drug delivery 
system includes all topically administered 
drug formulation intended to deliver the 
active ingredient into the general 
circulation (A1Saidan 2004). Transdermal 
therapeutic systems have been designed to 
provide controlled continuous delivery of 
drug via spleen to the systemic circulation. 
The ideal characteristic of TDDS involves. 
Ö NON-irritant  
Ö Small and flexible  
Ö Absence of problem. 
Ö Reliability  
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Ö Capacity  
Ö Targeting 
Ö The polymer must not decompose 
on storage or during shelf life. 
Ö The cost of the polymer stoned be 
weigh  
Ö It should adhere quickly to moist 
tissue and should possess some site 
specificity.  
Ö Agent independent. 
The transdermal drug delivery systems are 
designed to support the passage of drug 
substances from the spleen to the systemic 
circulation (Benowitz 1992). The basic 
components of device include polymers 
matrix, drug, excipients and adhesives 
packaging. 
 
Materials and Methods  
The Present work was performed to 
prepare and evaluate Transdermal patches 
of Indomethacine. It was carried out as 
follows. 
Ö Casting of plain transdermal patches. 
Ö Preparation of drug incorporated 
polymeric films. 
Ö Physico-chemical evaluation of 
transdermal patches which includes 
Percentage moisture absorption, 
percentage moisture loss, swelling 
index, time taken for swelling, water 
yapour transmission rate, thickness, 
weight uniformity and folding 
endurance.In vitro diffusion studies of 
transdermal patches. 
 
Standard curve for indomethacine 
Primary stock solution  
Indomethacine of 100mg was 
accurately weighed and dissolved in water 
to obtain 100ml of solution with a 
concentration of 1000mcg/ml (Table 1). 
 
Table 1.  Standard curve data for 
indomethacine 
Concentration 
[mcg/ml] 
Absorbance 
1 0.008 
2 0.014 
3 0.018 
4 0.024 
5 0.028 
6 0.034 
7 0.040 
8 0.046 
 
Secondary stock solution  
1 ml of primary stock solution was 
diluted to 100ml with water to get a 
concentration of 10mcg/ml from the 
secondary stock solution aliquots ranging 
from 1ml to 8ml were pipette out and dilute 
to 10ml with water to get the concentration 
range of 1mcg/ml to 8mcg/ml. The 
absorbances were measured at 296 nm and 
the values are determined. 
 
Table 2 Composition of formulation 
Batch code Polymers Solvent Plasticizer 
HPMC 
KAM % 
EC % Eudragit 
RLPO % 
Chloroform 
(ml) 
Glycerine 
% w/w 
B1 1 1 1 2.5 30 
B2 2 1 1 2.5 30 
B3 1 2 1 2.5 30 
B4 1 1 2 2.5 30 
B5 2 2 1 2.5 30 
B6 2 1 2 2.5 30 
B7 1 2 2 2.5 30 
B8 2 2 2 2.5 30 
Concentration of plasticizer = 30% w/w; Amount of drug loaded in each film 10 mg 
1% w/v = 50 mg; 2% w/v = 100 mg; 3% w/v = 150 mg 
Solvent casting technique    
The films were prepared by the 
method of solvent casting technique (Cevc 
2003). Fabrication of drug reservoir films 
with hydroxy propyl methyl cellulose, 
ethyl cellulose and Eudragit. Accurately 
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weighed quantity of hydroxy propyl 
methyl cellulose, Hydroxy propyl ethyl 
cellulose and Eudragit of composition of 
different formulations get mixed with 10mg 
of Indomethacine. Then add 2.5ml distilled 
water. Then there solutions were mixed to 
get a clear solution. Glycerin was added as 
plasticizer. Then it was poured over the 
mercury surface in a petridish and allowed 
to dry at room temperature (Table 2). 
 
Table 3  In vitro drug release data for batch-6 
Time in 
minutes 
Square 
root of 
time 
Cumulative 
drug release 
[%] 
5 2.236 25.93 
10 3.612 58.13 
15 3.873 72.43 
20 4.472 88.08 
Physico–chemical evaluation 
Percent moisture absorption  
The percent moisture absorption tests 
were carried out to check the physical 
stability of the transdermal films at high 
humid condition (Florance 1994). In the 
Present Study; the Moisture absorption 
capacities of the film were determined as 
follows. Three 1.00 cm diameter films were 
cut out and weighed accurately, and allow 
the films to keep in a desiccators containing 
saturated solution of aluminums chloride, 
keeping the humidity inside the 
desiccators, at 79.5% the films were 
removed after 3 days. Weigh it and the 
percentage moisture was calculated 
average percentage moisture of three films 
was found. 
 
Percentage moisture loss  
This test was also carried out to check 
the integrity of films at dry condition. Three 
1.00cm diameter films were cut out and 
weighed accurately and kept in a 
desiccators containing fused anhydrous 
calcium chloride (Rim 2005). After 72 h the 
films were removed and weighed. Average 
Percentage Moisture Loss of three films 
was found out.  
Percentage Moisture Loss = [(initial 
weight final weight) / initial weight] x 100. 
 
Swelling index 
Three films are taken each batch and it 
is put in pH  6.6 phosphate buffer and the 
weight is measured every three minutes; till 
the weight becomes constant.  
 
Water vapour transmission rate   
For water vapour transmission rate 
glass vials of equal diameter were used as 
transmission cells. These transmission cells 
were washed thoroughly and dried in an 
oven. About 1gm of anhydrous calcium 
chloride was taken in the cells and the 
polymer films were fixed over the brim 
with the help of the solvent (Riciere 2001). 
The cells were accurately weighed; kept in 
a closed desiccators containing saturated 
solution of KCl to maintain humidity of 
84% RH. The cells taken weighed after 6, 
12, 24,36 ,48, 72 h of storage. The amounts 
of water vapour transmitted were found 
using the formula. 
Water vapour Transmission Rate= Final 
weight - initial weight/ time × Area 
Water vapour Transmission Rate is usually 
expressed as the number of grams of 
moisture grams / h /sq from the data 
obtained, water vapour Transmission rate 
was calculated.   
 
Thickness 
Thickness of the films were measured 
at six different points using a screw gauge 
and average thickness of three films were 
found out. 
 
Weight of films 
Each film was weighed individually 
and average weights of three films were 
found out. 
 
Folding endurance 
It was determined by repeatedly 
folding a small strip of film at the same 
place, till it broke. The number of times the 
film could be folded at the same place 
without breaking gave the value of folding 
endurance (Prausnitz 2004). 
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Drug content 
A film size of 1cm was cut and 
dissolved in phosphate buffer. After adding 
suitable reagent and dilution, optical 
density was found out at 269nm. The 
average drug content of the three buccal 
films was determined. 
 
In vitro drug release studies for 
indomethacine 
Here, dissolution test apparatus USP 
[Paddle type] was employed throughout 
the study. The medium employed was 0.1N 
HCl at 37o C room temperature. The 
dissolution was carried out at an rpm 
maintained at 100 within a stipulated 
interval of 15 minutes (Jain 2003). 
A film of size diameter was cut and 
introduced into the cylinder filled with 
equal quantity of 0.1n HCL as the medium 
(Vavrova 2005). Samples of 10ml were 
withdrawn at every 15 minutes duration 
for continuous 2 h. The volumes of sample 
withdrawn were replaced by the same 
volume of dissolution medium (Nicoli 
2001). Filter the above sample and then 
taken 5ml from each sample and made at 
50ml with the medium. The withdrawn 
samples were analyzed by using visible- 
UV- spectrophotometer at 269nm using 
reagent blank (Table 3). 
 
Results and Discussion 
In the present study, the transdermal 
patches of indomethacine were prepared by 
using different polymers such as HPMC 
KAM, EC and Eudragit RLPO by solvent 
casting technique. In vitro dissolution study 
of drug along with different combination of 
polymers HPMC, EC and Eudragit RLPO 
has been performed. The higher rate and 
percentage of release of drugs in film 
containing less concentrations of EC in 
batch B-6 [HPMC: EC: Eudragit]-2:1:2] has 
been performed. As the percentage of EC 
was reduced, the rate of release of drug was 
increased. Hence moreover; the batch B-6 
shows the best moisture of films and the 
graph representing the best sustained drug 
release. Film with batch code B-6 shows 
better stability and suitability. 
Conclusion 
The formulation B-6 containing 2 parts 
of HPMC, 2 parts of Eudragit and 1part of 
EC has shown best release in concentration 
independent manner. Higuchis plot 
revealed that the predominant mechanism 
of drug release is diffusion. Hence the 
formulation B-6 achieved the objectives of 
present study such as reducing the dose, 
improving bioavailability by avoiding first 
pass metabolism and it may have better 
patient compliance. 
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